drugset / Trial / NCT00006221

BMS-247550 in Treating Patients With Advanced Cancers

NCT00006221

Phase 1 Completed 54 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of BMS-247550 in treating patients who have malignant solid tumors or lymphoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start
2000-11
Primary completion
2005-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ixabepilone Small molecule Intravenous